CMK SELECT
43 Route 46 East, Suite 705 Pine Brook, NJ 07058 USA
Rachel Phone: (973) 244-6060

FORGOT YOUR DETAILS?

+ Filters

Select one or more of the filter options below

CLOSE

Resource Center

Co-Promotion Optimization

AUTHOR: CMK SELECT

A notable pharmaceutical company had agreed to co-promote a drug and, in turn, was obligated to provide a list of contractual deliverables to the partner…

CONTINUE READING

Putting Theories Into Practice: Developing Risk Mitigation Strategies

AUTHOR: Kirk Dackow

In a recent article, Risk Management and Disaster Recovery in the Age of COVID-19, we discussed how we can gain valuable risk management insights by…

CONTINUE READING

Assessing the Value of Project Management in Medical Affairs

AUTHOR: Jennifer Schaefer

Our previous posts in this series reviewed the history and evolution of Medical Affairs departments in the pharma industry, noting how the growth of these…

CONTINUE READING

Project Management: How Medical Affairs Receives Value Every Day

AUTHOR: Jennifer Schaefer

In our prior article, we discussed the history and evolution of Medical Affairs departments, and reviewed how these departments have grown to perform so many…

CONTINUE READING

Risk Evaluation and Mitigation Strategies (REMS) B2B Services

AUTHOR: CMK SELECT

The Challenge A pharmaceutical technology company originally created a tool to validate the safety of medications, and while the tool effectively met the initial goal,…

CONTINUE READING

Project Management: An Increasingly Important Aspect of Medical Affairs

AUTHOR: Jennifer Schaefer

In prior articles, we have discussed the critical role played by pharmaceutical companies’ Medical Affairs departments, particularly related to product launch preparations and execution. Now…

CONTINUE READING

Case for an IT-enabling Business Strategy for companies in the Life Sciences Industry

AUTHOR: D. Douglas

The major trends in the life sciences industry are profoundly affecting the way we all work – from conducting research to distributing products, and everything…

CONTINUE READING

The Rising Value of Medical Affairs – Engagement with External Stakeholders (KOLs, TLs, EEs)

AUTHOR: N. Borinshteyn

The ever-evolving relationship between the pharmaceutical industry and its key opinion leaders (KOLs) has been a hot topic for a while, and there are several…

CONTINUE READING

Clinical Data Standards

AUTHOR: CMK SELECT

Following the December 17, 2014, FDA binding guidance that all pharma studies starting after December 17, 2016, must conform to a set of FDA-sponsored standards,…

CONTINUE READING

Medical Events Compliance

AUTHOR: CMK SELECT

A major pharmaceutical company was in need of a review and approval process to help streamline the planning and execution of its external medical events.…

CONTINUE READING

The Continuously Increasing Value of Medical Affairs in Product Launches – Part II

AUTHOR: N. Borinshteyn

As we’ve already begun to look into in Part I of this two-part blog, Medical Affairs teams play a critical role in bringing new treatment…

CONTINUE READING

LIKE OUR PAGE

FOLLOW US

GET LINKED IN

TOP